Immune-Based Therapy Under Evaluation for Treatment of COVID-19
Read the entire section on Immune-Based Therapy Under Evaluation for Treatment of COVID-19, click on the subsections (Blood-Derived Products, Immunomodulators , Table 3a. Immune-Based Therapy Under Evaluation for the Treatment of COVID-19: Clinical Data to Date, Table 3b. Characteristics of Host Modifiers and Immune-Based Therapy Under Evaluation for the Treatment of COVID-19) on your left and read ALL the provided content.
Click https://www.covid19treatmentguidelines.nih.gov/immune-based-therapy/ link to open resource.